We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
ClinicalTrials.gov Menu

PVB With vs. Without Clonidine for Ventral Hernia Repair

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02505204
Recruitment Status : Suspended
First Posted : July 22, 2015
Last Update Posted : January 18, 2022
Information provided by (Responsible Party):
Zoher Naja, Makassed General Hospital

Brief Summary:

Paravertebral block (PVB) combined with light intravenous sedation was associated with a short hospital stay, less post-operative nausea and vomiting and reduced analgesic consumption compared to general anesthesia for ventral hernia repair. Given the effectiveness of PVB in the ventral hernia repair, it would be beneficial to study the effect of PVB with versus without clonidine in elderly patients.

Patients will be randomly allocated to one of 2 groups with 30 patients in each, using the sealed envelope technique. Group one will receive PVB with clonidine while group 2 will receive PVB with placebo.

Condition or disease Intervention/treatment Phase
Ventral Hernia Repair Other: Clonidine Other: Placebo Not Applicable

Show Show detailed description

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 60 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
Primary Purpose: Other
Official Title: Paravertebral Block With Versus Without Clonidine for Patients Undergoing Ventral Hernia Repair: A Prospective Double-blinded Randomized Study
Actual Study Start Date : August 1, 2015
Estimated Primary Completion Date : April 2023
Estimated Study Completion Date : April 2023

Resource links provided by the National Library of Medicine

Arm Intervention/treatment
Experimental: Clonidine
Will receive bilateral PVB with clonidine.
Other: Clonidine
The anesthetic mixture will contain: lidocaine 2% 7 mL, lidocaine 2% 6 mL with epinephrine 5µg.mL-1, bupivacaine 0.5% 5 mL, and clonidine 2 mL.

Placebo Comparator: Placebo
Will receive bilateral PVB with placebo.
Other: Placebo
the same anesthetic mixture will be administrated however the clonidine will be substituted with 2 mL saline.

Primary Outcome Measures :
  1. Hemodynamic stability recorded from electrocardiogram and pulse oximeter [ Time Frame: within the first 48 hours after surgery ]
    Compare the hemodynamic stability between the two groups

Secondary Outcome Measures :
  1. Postoperative nausea and vomiting recorded via questionnaire [ Time Frame: within the first 48 hours after surgery ]
    Comparison of postoperative nausea and vomiting between the two groups

  2. Postoperative analgesic consumption recorded via questionnaire [ Time Frame: within the first 48 hours after surgery ]
    Comparison of analgesic consumption between the two groups

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information
Ages Eligible for Study:   65 Years and older   (Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Patients scheduled for ventral hernia repair whose age is 65 years and older
  • and with ASA greater or equal to 2

Exclusion Criteria:

  • History of allergic reactions to local anesthetics
  • Bleeding diatheses
  • Spinal abnormality

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02505204

Layout table for location information
Makassed General Hospital
Beirut, Lebanon
Sponsors and Collaborators
Makassed General Hospital
Layout table for investigator information
Principal Investigator: Zoher Naja, MD Chairperson of Anesthesia department
Layout table for additonal information
Responsible Party: Zoher Naja, Chairperson of Anesthesia and Pain Management Department, Makassed General Hospital
ClinicalTrials.gov Identifier: NCT02505204    
Other Study ID Numbers: 07/09/2015
First Posted: July 22, 2015    Key Record Dates
Last Update Posted: January 18, 2022
Last Verified: January 2022
Keywords provided by Zoher Naja, Makassed General Hospital:
paravertebral block
hemodynamic stability
Additional relevant MeSH terms:
Layout table for MeSH terms
Hernia, Ventral
Pathological Conditions, Anatomical
Hernia, Abdominal
Sensory System Agents
Peripheral Nervous System Agents
Physiological Effects of Drugs
Antihypertensive Agents
Autonomic Agents
Adrenergic alpha-2 Receptor Agonists
Adrenergic alpha-Agonists
Adrenergic Agonists
Adrenergic Agents
Neurotransmitter Agents
Molecular Mechanisms of Pharmacological Action